FDA — authorised 17 January 2012
- Application: BLA125327
- Marketing authorisation holder: BTG INTERNATIONAL INC
- Local brand name: VORAXAZE
- Indication: INJECTABLE — INJECTION
- Status: approved
🇺🇸 Voraxaze in United States
FDA authorised Voraxaze on 17 January 2012
Marketing authorisations
FDA — authorised 17 January 2012
- Marketing authorisation holder: BTG INTERNATIONAL INC
- Status: approved
Voraxaze in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Metabolic approved in United States
Frequently asked questions
Is Voraxaze approved in United States?
Yes. FDA authorised it on 17 January 2012; FDA authorised it on 17 January 2012.
Who is the marketing authorisation holder for Voraxaze in United States?
BTG INTERNATIONAL INC holds the US marketing authorisation.